Friday, September 11, 2026

Unlocking Triple Negative Breast Cancer: How Gene-Protein Analysis Predicts Treatment Success

A study reveals that analyzing genetic and protein data can predict chemotherapy effectiveness in triple-negative breast cancer, aiding personalized treatment.

Dongkoo Bio&Pharma Invests 1 Billion KRW in GenomAndCompany: What This Means for ADC Drug Development

Dongkoo Bio&Pharma invests 1 billion KRW in Genome & Company to enhance antibody and ADC drug development strategies.

SK Telecom, SK Biopharmaceuticals Use AI to Identify Drug Candidates for Hard-to-Treat Cancer Targeted Therapies

SK Telecom and SK Biopharmaceuticals use AI to identify early-stage cancer therapy candidates, reducing drug discovery time by over 60%.

Tag: Prix Galien

North KoreaKoreaKimMilitaryAISouth Koreamarketrelationsdevelopment

Yuhan’s Leclaza Wins Best Pharmaceutical Product at Asia’s First Prix Galien Awards

Yuhan Corporation's lung cancer drug 'Lecanza' wins Best Pharmaceutical Product at the inaugural 'Prix Galien' in Asia.

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.